BTG SPECIALTY PHARMACEUTICALS
The BTG Specialty Pharmaceuticals business develops, manufactures and commercializes life-saving antidotes used in hospitals and emergency care settings, including the clinically proven and leading products CroFab®, DigiFab®, and Voraxaze®.
BTG SPECIALTY PHARMACEUTICALS
Industry:
Biotechnology Manufacturing Pharmaceutical
Address:
Conshohocken, Pennsylvania, United States
Country:
United States
Website Url:
http://www.btgsp.com
Total Employee:
51+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network IPv6 Google Maps JsDelivr
Similar Organizations
Choice Therapeutics
Choice Therapeutics develops, manufactures and commercializes medical devices for burns, advanced wound care, and surgical site infections.
NUCRYST Pharmaceuticals
NUCRYST Pharmaceuticals develops, manufactures and commercializes medical products that fight infection and inflammation using
Official Site Inspections
http://www.btgsp.com Semrush global rank: 6.9 M Semrush visits lastest month: 707
- Host name: aa089eb6179d1ae2b.awsglobalaccelerator.com
- IP address: 13.248.160.137
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "BTG Specialty Pharmaceuticals"
SERB completes acquisition of BTG Specialty ... - SERB …
Mar 1, 2021 Our current portfolio of antidotes counteracts certain snake venoms and the toxicity associated with some heart and cancer medications. To learn more, please visit: btgsp.com. …See details»
BTG Specialty Pharmaceuticals - Crunchbase Company Profile
The BTG Specialty Pharmaceuticals business develops, manufactures and commercializes life-saving antidotes used in hospitals and emergency care settings, including the clinically proven …See details»
Homepage - SERB Pharmaceuticals
SERB began in the 1950s as Société d’Études et de Recherches Biologiques (Company for Biologic Study and Research). Today SERB has the broadest antidote portfolio in the world, …See details»
SERB completes acquisition of BTG Specialty ... - Markets Insider
LONDON, March 2, 2021 /PRNewswire/ -- SERB Specialty Pharmaceuticals ('SERB'), a leading European specialty pharmaceutical group focused on prescr...See details»
SERB completes acquisition of BTG Specialty Pharmaceuticals to …
Mar 2, 2021 Jeremie Urbain, CEO of SERB, said: "BTG Specialty Pharmaceuticals and SERB are an excellent strategic fit, with complementary portfolios, geographies, and capabilities.The …See details»
BTG Specialty Pharmaceuticals - PitchBook
BTG Specialty Pharmaceuticals General Information Description. Developer of specialty pharmaceuticals typically used in emergency rooms and intensive care. The company …See details»
SERB acquires BTG Specialty Pharmaceuticals - Crunchbase
Dec 1, 2020 Acquiring Organization: SERB Brussels-based specialty pharma company. Announced Date Dec 1, 2020; Completed On Date Mar 2, 2021; Acquisition Type Acquisition; …See details»
SERB completes acquisition of BTG Specialty Pharmaceuticals
Mar 2, 2021 Our current portfolio of antidotes counteracts certain snake venoms and the toxicity associated with some heart and cancer medications. To learn more, please visit: btgsp.com. …See details»
Thomas Kolaras Joins SERB and BTG Specialty Pharmaceuticals as …
PHILADELPHIA – 11 April 2022 – SERB and BTG Specialty Pharmaceuticals are pleased to announce that Thomas Kolaras has been named the group’s new Chief Commercial Officer for …See details»
BTG Specialty Pharmaceuticals - Overview, News & Similar
BTG International Achieves Finalist Status in Four Categories at the Prestigious Australian Accounting Awards Sydney, Australia--(Newsfile Corp. - June 8, 2023) - BTG International, …See details»
Home | BTG Specialty Pharmaceuticals
We provide rescue medicines typically used in emergency rooms and intensive care units to treat patients for whom there are limited treatment options. We are dedicated to delivering quality …See details»
SERB receives EU approval for Voraxaze® (glucarpidase) as Rescue ...
London, Jan. 14, 2022 (GLOBE NEWSWIRE) -- SERB and BTG Specialty Pharmaceuticals today announced that the European Commission has granted marketing authorisation for …See details»
SERB completes acquisition of BTG Specialty Pharmaceuticals to …
London, 2nd March 2021: SERB Specialty Pharmaceuticals (“SERB”), a leading European specialty pharmaceutical group focused on prescription medicines that address rare and life …See details»
Ben Watt Joins SERB and BTG as Group CFO
LONDON – 21 October 2021 – SERB and BTG Specialty Pharmaceuticals are pleased to announce that Ben Watt has been named the group’s new Chief Financial Officer. Ben is an …See details»
SERB receives EU approval for Voraxaze® (glucarpidase) as
Jan 14, 2022 Contact Data Chris Sampson BTG Specialty Pharmaceuticals +44 7773 251 178 [email protected]See details»
Firefighter Promise™ - CYANOKIT
If you have any questions, you can contact SERB Customer Service at 1-844-293-0007 or email [email protected]. INDICATION CYANOKIT is indicated for the treatment of known …See details»
SERB receives EU approval for Voraxaze ... - SERB Pharmaceuticals
14 January 2022 – SERB and BTG Specialty Pharmaceuticals announced that the European Commission has granted marketing authorisation for Voraxaze® (glucarpidase) to reduce toxic …See details»
BTG Specialty Pharmaceuticals advances global regulatory …
Sep 28, 2021 WEST CONSHOHOCKEN, Pa., Sept. 28, 2021 /PRNewswire/ -- BTG Specialty Pharmaceuticals announced that Ohara Pharmaceutical Co., Ltd. has obtained ma...See details»
BTG Specialty Pharmaceuticals advances global regulatory …
Sep 27, 2021 West Conshohocken, PA, 28 September 2021: BTG Specialty Pharmaceuticals announced that Ohara Pharmaceutical Co., Ltd. has obtained marketing authorization for …See details»
Join us - SERB Pharmaceuticals
For over 30 years our companies have made treating complex and life-threatening conditions possible, supporting clinicians, healthcare systems and governments while offering hope to …See details»